On October 27, CME Group Inc. fell 3.23% in Regular Trading, trading at $298.08 per share, with turnover of $141 million.
The most recent development was that Rothschild & Co Redburn raised its price target on CME Group Inc. to $347 from $330, but the stock still moved lower during the session, indicating the target increase did not provide immediate support for the shares.
As background, CME Group Inc. reported third-quarter adjusted EPS of $3.02, above the $2.99 consensus, while revenue rose 13% year over year to $1.74 billion, also ahead of expectations. Third-quarter global average daily volume reached a record 29.4 million contracts, with international average daily volume up 22% to 9 million contracts. Other firms had also lifted targets earlier in October, including Autonomous Research to $311 and Morgan Stanley to $337.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments